Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cyberonics, Inc. Issues FY 2013 Guidance In Line With Analysts' Estimates


Wednesday, 6 Jun 2012 07:00am EDT 

Cyberonics, Inc. announced that for fiscal 2013, it expects net sales in the range of $241-$244 million, income from operations will be in the range of $70-$72 million. The anticipated amount of the medical device tax, scheduled to be implemented on January 1, 2013, is excluded from income from operations guidance, but included in net income and diluted earnings per share guidance. Net income for fiscal 2013 is expected to be in the range of $41.5-$43.5 million. The Company expects diluted earnings per share (EPS) will be in the range of $1.49 to $1.59. Guidance excludes any unusual items or discrete tax items that may occur during the year, and reflects information available at this time. According to I/B/E/S Estimates, analysts were expecting the Company to report EBIT of $70 million, net income of $43 million, EPS of $1.54 and revenue of $243 million for fiscal 2013. 

Company Quote

62.02
0.77 +1.26%
17 Apr 2014